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ABSTRACT
Purpose: The efficacy of one remote monitoring system was reviewed in order to explore if optimal 
self-management of diabetes was achieved. Methods: Medical records of 214 patients with diabetes 
were reviewed from seven diabetes clinics within a single Health & Social Care trust using a remote 
monitoring solution to help patients self-manage their condition. Data on HbA1c, blood glucose, 
blood pressure and body mass index were obtained from the patient’s medical record, before and after 
using the remote monitoring solution. Results: The average age of users was 61 years: 60% of the 
sample were male. The average time living with diabetes was 14 years; the mean duration with remote 
telemonitoring was 147 days. A greater reduction in HbA1c was seen with female users compared to 
males 2.37% and 0.87%, respectively. Conclusion: Remote telemonitoring provided the opportunity 
to collect comprehensive data, allowing patients to be maintained at home, while showing significant 
improvement in their HbA1c and better overall management of their diabetes
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INTRoDUCTIoN
Globally, diabetes mellitus is considered to be an epidemic and a growing burden on public health 
(Matuleviciene, et al., 2014). It is associated with a significant morbidity and mortality (Schwartz & 
Scheiner, 2012). It has been estimated that 385 million people worldwide live with Diabetes and the 
number is predicted to rise to 500 million in 2030 (Matuleviciene, et al., 2014). In the UK, there are 
some four million people diagnosed with diabetes and an estimated additional 590,000 that are not 
yet diagnosed (Diabetes UK, 2015). The costs associated with diabetes account for almost 10% of the 
NHS primary care budget with a daily average expenditure of £2.2m on prescriptions for managing 
the condition (Matuleviciene, et al., 2014) (Lacobucci, 2014).
The key to good self-management of diabetes is to understand the importance of regular blood 
glucose measurement and the need for good blood glucose control together with a strong belief in 
one’s ability to achieve target levels. Levels of blood glucose vary dynamically from one individual 
to another and a recommended target range for blood glucose is determined by the healthcare team 
(Diabetes.co.uk, Blood Sugar Level Ranges). The target is individualised and based on the duration of 
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diabetes, age, comorbid conditions, micro/ macrovascular diseases, hypo/ hyperglycaemia awareness 
and other individual considerations such as patient’s lifestyle and dietary habits (ADA, Checking 
Your Blood Glucose, 2015).
The American Diabetes Association suggests the blood glucose target in those with diabetes 
should be 4.4 to 7.2 mmol/L (80 to 130 mg/dL) before meals and under 9.0 mmol/L (162 mg/dL) 
for people with type 1 diabetes (T1DM) and under 8.5 mmol/L (153 mg/dL) for people with type 2 
diabetes (T2DM) after meals (Diabetes.co.uk, Blood Sugar Level Ranges) (ADA, Checking Your 
Blood Glucose, 2015). These equate to glycated haemoglobin (HbA1c) levels of less than 7% or 48 
mmol/L for people with diabetes (ADA, Checking Your Blood Glucose, 2015) (Diabetes.co.uk, Guide 
to HbA1c). The healthcare team can get an overall idea of the average blood glucose levels over a 
period of time –usually every three months- by regular measurement of HbA1c (Matuleviciene, et al., 
2014) (Diabetes.co.uk, Guide to HbA1c). HbA1c is the gold standard marker for assessing long-term 
glycaemic control; however, it does not reveal the immediate hour-to-hour blood glucose levels like 
self-monitoring of blood glucose does and it does not provide detailed information about individual 
hyperglycaemic or hypoglycaemic excursions (Boutati & Raptis, 2009).
It has been established that a significant reduction in long-term diabetes-related complications is 
associated with tight glycaemic control (Boutati & Raptis, 2009) (Association, 2004). Self-monitoring 
of blood glucose (SMBG) is the process of collecting regular blood glucose information, often up to 
three to four times daily, to aid maintaining a constant stable glucose level (Diabetes.co.uk, Guide to 
HbA1c). SMBG is an important component of diabetes treatment and self-management. Results of 
monitoring are used to assess the efficacy of the therapy, while enabling people with diabetes to make 
appropriate day-to-day therapeutic choices in insulin dosage as well as to see the effect of diet and 
physical activities (Diabetes.co.uk, Guide to HbA1c) (Boutati & Raptis, 2009) (Association, 2004) 
(Benjamin, 2002). SMBG is a widely recommended daily routine as part of good self-management 
among people with T1DM or insulin-treated T2DM (Boutati & Raptis, 2009). However, it is still 
unclear as to what extent SMBG is useful and accepted in patients with non-insulin-treated T2DM 
(Boutati & Raptis, 2009) (Association, 2004) (Martin, et al., 2005). Self-management programs can 
empower patients by increasing confidence in their abilities, by teaching them skills and techniques 
to better self-manage their condition, and how to improve their interaction with the healthcare 
system – all of which can lead to better management of chronic conditions like diabetes (Jaglal, et 
al., 2014). Within a few years, SMBG by patients has revolutionised management of diabetes but not 
without barriers including: the costs of SMBG, lack of understanding from patients about the health 
benefits and proper use of SMBG results, patient psychological and physical discomfort associated 
with finger-pricking for blood testing, the time consuming nature and inconvenience of testing, and 
for some the complexity of the technique (Association, 2004).
Through recent advances in technology, blood glucose monitors have been equipped with wireless 
technology to enable transmission of self-measured blood glucose readings to the healthcare team in 
real-time or when needed, via communication networks such as the internet or phone line (Medical 
Advisory Secretariat, 2009). The aims of such developments are to promote, empower and facilitate 
health and wellbeing within individuals, families and communities; to enhance professional practice 
through the use of information management and information and communication technology; and 
to reduce unnecessary hospitalisation (International, 2012). Recently, the term Connected Health 
Technology has been introduced in the UK (Roberts, et al., 2010) encouraging organisations to share 
information across boundaries and enable healthcare providers to extend their care to patients’ homes, 
helping them to relieve the increasing burden of chronic diseases including diabetes (AHRQ, 2014). 
Monitoring patients remotely while supporting the transmission and interpretation of data may help 
patients’ better control their blood glucose levels. Evidence indicates that intensive glucose monitoring 
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may reduce the likelihood of complications associated with diabetes as outlined in Jaana and Pare’s 
comprehensive systematic assessment of observed effects of 17 home telemonitoring solutions with 
automated transmission of data on patients’ health status from home to the respective healthcare setting 
(M & G, 2007). At the clinical level, the close management and monitoring of diabetes patients have 
resulted in significant decreases in HbA1c, which suggests improved management of the medical 
condition. Nevertheless, the mainstream use of such technology is not fully supported (Macginnis, 
2012). Cochrane reviews on the use of technology within healthcare have identified the need for 
more robust evidence within this domain (Martin, Kelly, Kernohan, McCreight, & Nugent, 2008).
Given the importance of SMBG to diabetes care, the Health Service in Northern Ireland introduced 
an innovative telemonitoring service aiming to enable patients to control their diabetes and reduce 
the risk of serious complications (HSC, 2015). “Remote Telemonitoring Northern Ireland” (RT-NI) 
is a large-scale, clinically-led, managed monitoring service that was launched in 2011, aiming to 
improve health outcomes for people with chronic illness through better engagement with clinicians 
while enhancing the self-management process.
RT-NI is a system designed by a group of companies with complimentary expertise known 
as TF31 (NI, 2015). The patient is provided with a computerised hub – a small unit installed in the 
patient’s home along with linked ancillary equipment – a scale, a blood pressure monitor and a 
glucometer for SMBG. This provides a capability to measure various parameters such as weight, 
blood pressure, blood glucose, temperature, and oxygen levels in the body. The patient is invited to 
take measurements using a range of appropriate equipment. The unit is programed to ask a pre-set 
of “yes or no” questions determined by the healthcare provider. These measurements are checked 
regularly and if the readings are abnormal, the patients receive a phone call from the nurse to elicit 
further information. The nurse would assess the situation and if necessary, the physician would be 
consulted on the matter.
A systematic review by Mushcab (2015) on the impact of web-based remote monitoring 
on improving HbA1c of insulin-treated T2DM patients concluded that research on web-based 
telemonitoring solutions for self-management T2DM confirms that the use of telemonitoring systems 
is a viable approach to the management of T2DM and it effectively improves HbA1c levels (Mushcab, 
Kernohan, Wallace, & Martin, 2015). However, it also concludes that the understanding of how, why, 
and when technology can improve clinical care and quality of life for people with T2DM require further 
intensive and comprehensive investigation as well as the barriers to implementation and the impact 
and long-term sustainability of outcomes. In this paper we aim to establish the impact of RT-NI on 
HbA1c levels among users with diabetes. Analysis of existing data will help to identify candidate 
causal factors contributing to any observed change in patients living with diabetes.
In this paper, the aim is to evaluate the impact of using RT-NI had in self-managing diabetes 
mellitus by exploring existing records of RT-NI users, comparing the overall change in HbA1c levels 
in people with different types of diabetes mellitus. The findings of this evaluation present promising 
results and pronounced confidence in using remote monitoring in self-management of diabetes mellitus.
Methods
Study Design
This was a retrospective cohort study with data analysis from the records of people using RT-NI 
for self-managing diabetes looking principally for any change in HbA1c levels. Data were available 
for each participant prior to initiation of RT-NI within one large combined health and social care 
provider, serving 345,000 people with a budget of almost £500 million per year, collected from one 
location – Ulster hospital- it is a teaching hospital that provides acute services 250,000 people in 
Northern Ireland (Wikipedia, Ulster Hospital, 2016). Data were available for people with T1DM, 
T2DM, Latent Autoimmune Diabetes of Adulthood (LADA) and Impaired Glucose Tolerance (IGT) 
and who were receiving insulin or oral agents as treatment for their condition. Women with gestational 
diabetes, people with diabetes who did not need medication and/or people with complex or multiple 
morbidity conditions were excluded to avoid confounding results. Data were gathered from previous 
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Figure 1. Flowchart demonstrating the process of patient recruitment onto RT-NI and data retrieval for inclusion in retrospective 
review
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and current users of RT-NI within seven diabetes clinics. The RT-NI database held data on blood 
glucose, blood pressure and body weight. Data related to patient’s age, gender, duration of diabetes, 
body mass index (BMI) and HbA1c levels were extracted from the electronic medical records at the 
hospital. Some items were incomplete: missing data were imputed using mean values (see Figure 1).
Data Analysis
Descriptive analysis was carried out to both interrogate and provide summaries of the data sets 
exploring the sample and measures forming the basis of quantitative analysis of data, which includes 
Central Tendency measures (mean), Dispersion (Standard Deviation and range), variation with time 
(to show improvement over time), variation by gender and a paired sample t-test to compare means 
of measurements before and after provision of remote telemonitoring and SMBG. The usual 5% 
threshold of p values were used to test for significance.
Results
In total, 214 adult patients were recruited onto the RT-NI service from October 2011 to July 2015. The 
great majority were T2DM patients with 83.4% or T1DM patients 14.1%. Most 94% of the patients 
were insulin treated (see Table 1).
The average age of male users (n=134) was 63 (±13) years forming 60% of the sample; compared 
to the average age of 59 years (±14) for female users (n=91) (see Table 2). The average duration 
of RT-NI utilisation was 212 and 82 days, respectively. A paired sample t-test was performed using 
(SPSS version 20) to compare the before and after means of BMI, BG and HbA1c (see Table 3). 
There was a statistically significant improvement in blood glucose and HbA1c levels after using 
RT-NI for both female and male users.
For male users, the paired samples t-test revealed a statistical difference between the mean of BG 
(M=13.1 ±4.8) before using RT-NI and after (M=11.6 ±4.0) with t(134)=3.03, degree of freedom=133 
and p=0.003. The test also revealed a statistically significant improvement in HbA1c before (M=9.47 
± 2.09) and after using RT-NI (M=8.59 ±1.92), t(134)=4.94, degree of freedom=133 and p<0.001. 
However, the test failed to reveal a statistically reliable difference between the BMI mean before 
using RT-NI (M=33.6 ±6.7) and after (M=34.0 ±6.5), t(134)= -1.67 and a non-significant p value.
Slightly better results were achieved by the female users, the paired samples t-test has revealed 
a statistically reliable difference between the mean of BG (M=13.4 ±4.5) before using RT-NI and 
after (M=11.2 ±3.2) with t(91)=4.28, degree of freedom=90 and p<0.001. The test also revealed a 
statistically significant improvement in HbA1c before (M=10.8 ± 9.1) and after using RT-NI (M=8.5 
±1.3), t(91)=2.5, degree of freedom=90 and p=0.014.The test also failed to reveal a statistically 
reliable difference between the BMI mean before using RT-NI (M=34.6 ±9.2) and after (M=34.6 
±7.9), t(91)= 0.005 and a non-significant p value.
DISCUSSIoN
RT-NI is a mature technology and established service encompassing several diabetes clinics within 
Northern Ireland. However, there has been no in-depth evaluation of the technology and impact of 
service on diabetic control; therefore, this review provides useful evidence of its efficacy in improving 
glycaemic control and in supporting self-management in those with diabetes.
It is known that SMBG and BG data transmission play an important role in improving diabetes 
control. Indeed, it is highly recommended for insulin-treated patients (Mushcab, Kernohan, Wallace, 
& Martin, 2015). By remotely monitoring the patient, the clinical team was able to improve the 
patient’s result and help them achieve desired goals. Mainly users used RT-NI to transmit BG data, 
however, 73 users out of 214 used it to also transmit blood pressure and/or weight data as well. RT-
NI was well accepted by the users and 95% of them showed improvements in the long-term. Most 
patients accepted the technology and used it effectively and showed them improvement. Though, a 
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small number (N=11) did not cope well with RT-NI and stopped using the technology shortly after 
starting to use it. In spite of the slight difference in the average results of HbA1c between male and 
female users, both showed significant improvement in glycaemic control with a fall in HbA1c of 
.0.9% and 2.4%, respectively. However, the difference in the BMI results was minor and insignificant.
Table 1. Showing the number of RT-NI users, presented according to their gender and their diabetes type with the average 
duration of diabetes since diagnosis in years. It also shows the number of insulin and non-insulin treated users of both 
genders
Diabetes Type Male Avg Diabetes 
Duration in years 
(SD)




T1DM 20 15% 22 (±17) 12 13% 25.42 (±17.40) 14.1%
T2DM 110 82% 14 (±7) 77 85% 13.5 (±7.25) 83.4%
LADA 1 1% - 1 1% - 0.9%
Secondary 2 1% 7 (±2) 1 1% - 1.3%
IGT 1 1% - 0 0% 0 0.4%
Total 134 100% 15 (±8) 91 100% 13 (±12.33) 100%
Treatment
Insulin treated 124 93% 86 95% 94%
Non-insulin Treated 
(All T2DM)
10 7% 5 5% 6%
Table 2. The average age, the total number of RT-NI users and returning users from October 2011 to July 2015
Users Returning Users Ave Age
Male 134 60% 8 4% 63 (± 13.12)
Female 91 40% 3 1% 59 (±13.98)
Total 225 100% 11 5% 61 (±13.55)
Table 3. results of paired samples t-tests performed to compare results of BMI (kg/m2), blood glucose (mmol/L) and HbA1c 
(DCCT-%) by gender
Paired Differences t df Sig. 








Female 34.58 34.58 .003 6.47 .68 -1.34 1.35 .005 90 .996
Male 33.55 34.04 -.494 3.42 .30 -1.08 .09 -1.67 133 .097
BG 
mmol/L 
Female 13.36 11.24 2.114 4.71 .49 1.13 3.09 4.29 90 .000
Male 13.05 11.58 1.461 5.57 .48 .51 2.41 3.04 133 .003
HbA1c 
DCCT-% 
Female 10.48 8.46 2.375 9.05 .95 .49 4.26 2.51 90 .014
Male 9.47 8.59 .875 2.05 .18 .53 1.23 4.95 133 .000
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Remote telemonitoring is still considered a novel intervention and still in the development stage 
but with potential to enhance outcomes (Meystre, 2005). There is a considerable value of remote 
telemonitoring even when using minimum amount of data such as (high/low) alerts can make the 
patient avoid hypo/hyperglycaemia episodes enabling the patients to self-manage their diabetes.
Technology advancements have proven their positive impact within time. The past couple of 
years the diabetes care witnessed a new technology developed by Abbott1 that exhibited great self-
management of T1DM without pricking fingers for blood testing. The Freestyle® Libre System 
allows the patient to scan his BG level using a reader and a wearable sensor (Assardo, 2016). The 
results of the clinical trial done using this technology presented promising results with 50 per cent 
reduction in serious hypoglycaemia and no increase in HbA1c levels in six months. However, where 
there is new advanced technology there is always the limitation of cost and funding especially in the 
less developed countries (Assardo, 2016).
CoNCLUSIoN
Diabetes is a global epidemic, challenging many countries on how to provide large-scale effective 
support services to help individuals self-manage their condition well. Remote telemonitoring of 
blood glucose can be an effective tool to manage diabetes, allowing patients to be monitored and 
supported while maintained in their homes. RT-NI provides accurate and comprehensive data in 
improving clinical outcomes. With 95 per cent long-term improvement in HbA1c levels amongst 
users, these encouraging results indicate that clinical care can be provided remotely for day-to-day 
self-management of diabetes and it may offer target for improving complications observed for patients 
with diabetes mellitus. In conclusion, the possibilities of data sharing towards telemedicine will be 
crucially beneficial and beyond expectations in managing diabetes and other chronic illnesses.
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